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uring the systemic inﬂammatory response, circulating
cytokines interact with the vascular endothelium,
resulting in activation and nuclear accumulation of
the nuclear transcription factor, nuclear factor kappa B
(NF
 
 
 
B). In turn, NF
 
 
 
B transactivates relevant proinﬂammatory
genes, resulting in an ampliﬁcation of the inﬂammatory
response. Because this scenario is potentially detrimental
to the host, mechanisms exist to limit this ampliﬁcation.
Using an in vitro system that mimics the vascular–interstitial
interface during inﬂammation (cell culture inserts), we
provide evidence for the existence of a novel negative
feedback mechanism on NF
 
 
 
B activity. We show that the
interleukin 1
 
 
 
–induced accumulation of nuclear NF
 
 
 
B in
 
human umbilical vein endothelial cell monolayers is
D
 
dramatically reduced when polymorphonuclear leukocytes
 
(
 
PMN) are allowed to migrate across these monolayers.
This effect does not appear to be due to PMN-derived
elastase or nitric oxide. Fixed PMN (adhere but do not
migrate) did not affect nuclear NF
 
 
 
B. Furthermore, cross-
linking of platelet-endothelial cell adhesion molecule-1
(PECAM-1), but not intercellular adhesion molecule-1,
reduces human umbilical vein endothelial cell nuclear
NF
 
 
 
B induced by interleukin 1
 
 
 
. Finally, interaction of
PMN with PECAM-1–deﬁcient endothelial cells does not
reduce nuclear NF
 
 
 
B. These observations indicate that
engagement of PECAM-1 by emigrating PMN is a pivotal
event in this negative feedback on NF
 
 
 
B activity.
 
Introduction
 
A systemic inflammatory response is a frequent consequence
of a severe bacterial infection or trauma and can impact on
organ systems remote from the initial insult (Bone, 1995;
Lush and Kvietys, 2000). The release of bacterial products
and other proinflammatory mediators from the affected tissue
results in an increase in plasma concentrations of cytokines
(e.g., tumor necrosis factor 
 
 
 
 [TNF-
 
 
 
],* interleukin 1
 
 
 
[IL-1
 
 
 
], etc.). These cytokines activate both circulating
neutrophils (polymorphonuclear leukocytes, PMN) and the
vascular endothelium. Activated PMN increase their surface
levels and/or activation state of adhesion molecules (e.g.,
cluster of differentiation-18, CD18) and become less deform-
able (Hogg and Doerschuk, 1995; Linderkamp et al., 1998;
Lush and Kvietys, 2000). Endothelial cell activation also
involves up-regulation of adhesion molecules (e.g., intercellular
adhesion molecule 1 [ICAM-1], the ligand for CD18) and
structural alterations, such as swelling and pseudopod for-
mation (Panes et al., 1995; Goddard et al., 1998). These
changes in the activation state of PMN and endothelium
facilitate PMN invasion of various organ systems, where they
contribute to tissue injury. If unchecked, this sequence of
events can lead to multiple organ dysfunction, and ulti-
mately, death.
The systemic inflammatory response appears to be a self-
amplifying phenomenon generated by the activation of nu-
clear transcription factors by circulating cytokines. One
transcription factor that is believed to be important in the
systemic inflammatory response is nuclear factor kappa B
 
(
 
NF
 
 
 
B; Collins et al., 1995; Stancovski and Baltimore,
1997; Winyard and Blake, 1997; Mercurio and Manning,
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1999; Bonizzi et al., 2000). In quiescent cells, NF
 
 
 
B (p50/
p65 heterodimer) is localized to the cytoplasm by virtue
of its association with inhibitory protein kappa B (I
 
 
 
B).
I
 
 
 
B apparently masks the nuclear localization sequence on
NF
 
 
 
B, and thereby prevents its translocation to the nucleus
(Henkel et al., 1992; Lin et al., 1995; Mercurio and Man-
ning, 1999). In cytokine-activated cells, I
 
 
 
B is phosphory-
lated, ubiquitinated, and subsequently degraded by the pro-
teasome pathway. The loss of I
 
 
 
B allows NF
 
 
 
B to enter the
nucleus and initiate the transcription of relevant proinflam-
matory genes, including those encoding for endothelial ad-
hesion molecules and various cytokines. Interestingly, NF
 
 
 
B
transcribes genes encoding for the same cytokines that mobi-
lized it to the nucleus. This positive feedback mechanism
could amplify the inflammatory state with severe conse-
quences to the host.
Fortunately, there are negative feedback mechanisms in
place that limit an excessive and prolonged inflammatory re-
sponse on NF
 
 
 
B translocation to the nucleus. For example,
NF
 
 
 
B transactivates the gene encoding for I
 
 
 
B (Brown et
al., 1993; Baldwin, 1996; Bonizzi et al., 2000). The result-
ant generation of I
 
 
 
B presumably binds to cytoplasmic
NF
 
 
 
B and prevents further translocation of this transcrip-
tion factor to the nucleus. This feedback inhibition assures a
transient response to the initiating signal and prevents an ex-
cessive, uncontrolled inflammatory response. Our previous
preliminary works (Cepinskas et al. 1998. 
 
FASEB J
 
. 12(5):
A801. Abstract) indicated that there might be an additional
negative feedback mechanism in place to control the sys-
temic inflammatory response. In that paper, we noted that
the increase in rat myocardial and lung nuclear NF
 
 
 
B in-
duced by sepsis (peritonitis) was enhanced when PMN emi-
gration was prevented by antibodies directed to CD18. This
observation suggested that PMN emigration into the lungs
and heart during the systemic inflammatory response could
reduce tissue nuclear NF
 
 
 
B. Herein, we provide evidence
that the IL-1
 
 
 
–induced increase in endothelial cell mono-
layer nuclear NF
 
 
 
B can be reduced if PMN are allowed to
migrate across these monolayers. Furthermore, engagement
of platelet-endothelial cell adhesion molecule 1
 
 (
 
PECAM-1)
on endothelial cells by PMN may be the mechanism by
which this negative feedback inhibition occurs.
 
Results
 
In ICAM-1–deficient mice, the peritonitis-induced 
increase in lung and heart MPO activity is decreased, 
whereas the increase in tissue nuclear NF
 
 
 
B activity 
is augmented
 
Previously, we have shown that cecal ligation and perforation
(CLP) in mice results in peritonitis and sepsis, a systemic
inflammatory response (Lush et al., 2001). As shown in Fig.
1 A, induction of peritonitis in wild-type mice resulted in an
increase in myeloperoxidase (MPO) activity in the lungs and
hearts of these animals. The increase in MPO activity in the
lungs and heart in response to CLP was substantially dimin-
ished in ICAM-1–deficient animals. As shown in Fig. 1 B,
the NF
 
 
 
B in nuclear extracts obtained from lungs and hearts
of wild-type mice subjected to CLP was increased. The
NF
 
 
 
B in nuclear extracts obtained from the lungs and hearts
of ICAM-1–deficient mice subjected to CLP was increased
to a greater extent than the levels noted in wild-type mice
subjected to the same procedure (Fig. 1 B, compare lane 3
with lane 4). These observations are in agreement with our
previous studies in rats (Cepinskas et al. 1998. 
 
FASEB J
 
.
12(5):A801. Abstract). As in the present work, induction of
peritonitis (CLP) resulted in an increase in MPO activity
Figure 1. PMN accumulation in the lung and heart of ICAM-1–
deficient mice is decreased during peritonitis, whereas tissue 
nuclear NF B is increased. Wild-type and ICAM-1–deficient mice 
were subjected to peritonitis (CLP). (A) The increase in MPO activity 
(index of PMN accumulation) was less in the lungs and hearts of 
ICAM-1 knockout (ICAM-1 KO) mice as compared with their wild-
type counterparts (WT). MPO activity was measured 6 h after induction 
of CLP. Values are means and SEM from six experiments. (B) The 
CLP-induced increase in NF B in nuclear extracts of the lungs and 
hearts was greater in ICAM-1 knockout mice (ICAM-1 KO). The 
nuclear extracts were obtained 6 h after induction of CLP and EMSA 
performed as described in Materials and methods. Results presented 
are representative of six experiments.T
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and nuclear NF
 
 
 
B in the hearts and lungs of rats. Antibod-
ies to CD18 prevented the CLP-induced PMN accumula-
tion in the lungs and hearts of rats, while exaggerating the
increase in nuclear NF
 
 
 
B. Thus, collectively, these findings
indicate that CD18/ICAM-1–mediated adhesive interac-
tions between PMN and endothelial cells can modulate the
systemic inflammatory response.
There are two possible explanations for these observations
based on the importance of CD18–ICAM-1 adhesive inter-
actions in PMN infiltration of tissues (Granger and Kubes,
1994; Kvietys et al., 1996; Panes and Granger, 1998; Wang
and Springer, 1998). The neutralization of ICAM-1 (geneti-
cally) and CD18 (antibodies) may have prevented PMN
emigration into the site of infection, the peritoneum,
thereby compromising the clearance of fecal bacteria and
their proinflammatory products. Ultimately, this would re-
sult in a greater systemic inflammatory response, e.g., exag-
gerated levels of circulating cytokines. The higher levels of
circulating cytokines could, in turn, induce a greater increase
in heart and lung nuclear NF
 
 
 
B. Alternatively, the preven-
tion of PMN emigration into the interstitium of the target
organs (heart and lung) may have directly impacted on the
CLP-induced increase in nuclear NF
 
 
 
B in these organs.
This latter possibility suggested that PMN transendothelial
migration may initiate a negative feedback signal to dimin-
ish nuclear levels of NF
 
 
 
B. In the present work, we mim-
icked the interstitial–vascular interface during sepsis by acti-
vating endothelial monolayers in culture inserts with IL-1
 
 
 
and inducing PMN transendothelial migration from the api-
cal to the basal aspects of the inserts by introducing platelet-
activating factor (PAF) into the basal compartment. This
approach allowed for a direct assessment of PMN transen-
dothelial migration in target organs in the absence of com-
plications induced by excessive cytokine production due to
lack of clearance of bacteria from the initial site of infection.
Herein, we provide evidence that PMN transendothelial mi-
gration initiates a negative feedback on endothelial cell nu-
clear NF
 
 
 
B.
 
Migrating PMN decrease nuclear NF
 
 
 
B 
in IL-1
 
 
 
/PAF-stimulated HUVECs
 
We used confocal microscopy to assess the negative impact
of PMN transendothelial migration on the IL-1
 
 
 
–induced
increase in human umbilical vein endothelial cell (HUVEC)
nuclear NF
 
 
 
B (Fig. 2 A). Under control (unstimulated)
conditions, p65 is localized to the cytoplasm of HUVECs
(Fig. 2 A, a). After stimulation with IL-1
 
 
 
/PAF, the p65 is
primarily localized to the nuclei of HUVECs (Fig. 2 A, b).
When PMN were allowed to migrate across the HUVEC
monolayers, there was a decrease in nuclear p65 (Fig. 2 A,
c). Of interest is the observation that, although there is some
staining for NF
 
 
 
B in the cytoplasm, the overall extent is
much less than under control conditions (Fig. 2 A, compare
a with c). The reason for the overall lack of cytoplasmic
staining after PMN migration is not clear, but may reflect
degradation of NF
 
 
 
B or modification of NF
 
 
 
B, such that it
is no longer recognized by the antibody.
To further address this issue, we used electrophoretic mo-
bility shift assay
 
 
 
(EMSA) to monitor nuclear NF
 
 
 
B. As
shown in Fig. 2 B (lane 1), activation of HUVECs grown to
confluence in cell culture inserts with IL-1
 
 
 
 (apical aspect)
and PAF (basal aspect) resulted in nuclear accumulation of
NF
 
 
 
B. This observation is consistent with previous reports
of cytokine-induced NF
 
 
 
B activation and translocation to
HUVEC nuclei (Stancovski and Baltimore, 1997; Lush et
al., 2000). When PMN were allowed to migrate across the
IL-1
 
 
 
/PAF-stimulated HUVEC monolayers, the nuclear
level of NF
 
 
 
B was dramatically diminished (Fig. 2 B, lane
2). The negative effect on HUVEC nuclear NF
 
 
 
B induced
by migrating PMN was dependent on the number of PMN
interacted with HUVECs. The greater the number of PMN
that were allowed to migrate across HUVEC monolayers,
the greater was the decrease in nuclear NF
 
 
 
B (Fig. 2 B, lanes
2–6). The finding that a decrease in nuclear NF
 
 
 
B was
noted even when the endothelial cell:PMN ratio was as low
as 10:1 (Fig. 2 B, lane 6) indicates that this phenomenon is
pathophysiologically relevant. Collectively, the data ob-
tained using EMSA and confocal microscopy indicate that
PMN transendothelial migration has a negative impact on
HUVEC nuclear NF
 
 
 
B. To our knowledge, this is the first
time that this phenomenon has been described.
Having demonstrated the negative impact of PMN
transendothelial migration on the IL-1
 
 
 
–stimulated increase
in HUVEC NF
 
 
 
B using two different approaches, we as-
sessed whether this phenomenon could be demonstrated us-
ing other cytokines to stimulate HUVECs. HUVECs were
activated with 10 ng/ml TNF-
 
 
 
 (R&D Systems) and 0.5
 
 
 
g/ml lipopolysaccharide (LPS; Sigma-Aldrich) rather than
IL-1
 
 
 
. Similar results were noted as with IL-1
 
 
 
, i.e., these
compounds increased HUVEC nuclear NF
 
 
 
B, and subse-
quent PMN transendothelial migration resulted in a de-
crease in HUVEC nuclear NF
 
 
 
B (unpublished data). These
latter observations indicate that PMN transendothelial mi-
gration can provide a negative influence on HUVEC nuclear
NF
 
 
 
B induced by a variety of cytokines. Because LPS, IL-
1
 
 
 
, and TNF-
 
 
 
 have all been implicated in the systemic in-
flammatory response (Lush and Kvietys, 2000), this negative
feedback on HUVEC nuclear NF
 
 
 
B may be very relevant to
this pathology. For the remainder of the experiments, we fo-
cused on IL-1
 
 
 
 as the cytokine prototype.
 
PMN-derived soluble factors do not play a role in the 
decrease in HUVEC nuclear NF
 
 
 
B induced by PMN 
transendothelial migration
 
In these experiments, we assessed whether PMN secrete or
discharge substances that are responsible for the decrease in
nuclear NF
 
 
 
B of IL-1
 
 
 
–stimulated HUVECs. PMN were
separated from HUVEC monolayers by placing them in the
apical compartment of cell culture inserts (0.4-
 
 
 
m pore di-
ameter) over the HUVEC monolayers in the basal compart-
ment (distance between PMN and HUVECs was 0.9 mm).
When PAF-activated PMN were coincubated with HU-
VECs in this system for 1 h, there was no detectable increase
in nuclear NF
 
 
 
B in naive HUVECs (unpublished data).
More importantly, the IL-1
 
 
 
–induced increase in nuclear
NF
 
 
 
B was not affected by subsequent addition of PMN and
PAF (unpublished data). These observations suggest that
PAF-activated PMN do not release substances that canT
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traverse 0.9 mm to influence HUVEC nuclear NF
 
 
 
B. How-
ever, this does not preclude the possibility that contact of
PMN with the endothelium is necessary for PMN-derived
soluble factors to be effective. Others have shown that adhe-
sion of PMN to biological surfaces renders them more sensi-
tive and reactive to inflammatory stimuli (Fuortes et al.,
1993; Furuno et al., 1997).
Previously, we have shown that activated PMN mobilize
elastase to the cell surface, where it plays an important role
in PMN transendothelial migration (Cepinskas et al.,
1999a). Others have shown that neutrophil-derived elastase
can also induce cell signaling in epithelial (Hashimoto et al.,
1999) and endothelial (Yamaguchi et al., 1998) cells. Thus,
several approaches were used to determine whether PMN-
derived elastase can decrease nuclear NF B in IL- /PAF-
stimulated HUVECs. Neutroplasts (neutrophilic cytoplasts)
prepared from 10
 7 M PAF-stimulated PMN were used,
rather that intact PMN. As shown in Fig. 3 A, migrating
Figure 2. PMN transendothelial migration across IL-1 –activated HUVEC monolayers reduces nuclear levels of the NF B. (A) In naive 
(unstimulated) HUVECs, the NF B p65 subunit (red fluorescence) is confined to the cytoplasm (a, arrow), i.e., there is no detectable NF B 
p65 in the nuclei. In IL-1 /PAF-stimulated HUVECs, the NF B p65 subunit is detected in the nuclei (b, arrowhead) with very little of the 
NF B p65 remaining in the cytoplasm (b, arrow). The IL-1 –induced nuclear staining for NF B p65 is decreased after PMN migration across 
HUVECs (c, arrowhead), while some cytoplasmic staining is present (c, solid arrow). Although the images were obtained after the bulk of the 
PMN added to the HUVEC monolayers had completed their passage across the monolayers, an occasional PMN was captured still in the 
process of migration (c, open arrow). Bar, 20  m. The experiment was repeated twice and similar results were obtained. Quantitation of this 
phenomenon was performed by counting the number of nuclei stained for NF B in 100 random cells. Under control conditions (a), 2% of the 
nuclei were stained; after stimulation of HUVECs with IL-1 /PAF (b), 97% of the nuclei were stained; and after PMN transendothelial migration 
(c), 22% of the nuclei were stained. (B) HUVECs in the apical compartment of culture inserts were stimulated with IL-1  for 4 h, and subsequently, 
PMN transendothelial migration was induced by PAF introduced into the basal compartment of the system (IL-1 /PAF). After PMN trans-
endothelial migration, nuclear extracts were obtained from the HUVEC monolayers and assessed for NF B using EMSA. PMN transendothelial 
migration decreased the IL-1 –stimulated HUVEC nuclear content of NF B. As the number of PMN allowed to interact and migrate across 
HUVEC monolayers was increased, the greater was the decrease in the levels of nuclear NF B (lanes 2–6). Lane 7 shows the control competition 
assay (Comp.) using 50-fold excess of the unlabeled oligonucleotide. Results presented are representative of three experiments.T
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neutroplasts were also capable of inducing a decrease in HU-
VEC nuclear NF B. This observation indicates that PMN
degranulation (extracellular release of enzymes) is not re-
quired for the negative impact of PMN migration on HU-
VEC nuclear NF B. However, the cell membranes of neu-
troplasts obtained from PAF-activated PMN are enriched in
elastase (Cepinskas et al., 1999a). Thus, it was quite possible
that membrane-bound elastase could be involved. However,
the elastase inhibitor L658 758 (100  M; Merck) did not
affect the decrease in NF B in HUVEC nuclei induced by
migrating intact PMN (Fig. 3 B). In another series of exper-
iments, purified human elastase (0.1–0.5  g/ml for 15 min;
DakoCytomation) was added to the IL- /PAF-stimulated
HUVECs. This maneuver also failed to affect the increase in
HUVEC nuclear NF B induced by IL-1  (unpublished
data). Together, these experiments indicate that PMN-derived
elastase does not play a role in the negative effect on endo-
thelial nuclear NF B induced by migrating PMN.
Nitric oxide (NO) has been implicated as an inhibitor of
endothelial cell NF B (De Caterina et al., 1995; Spiecker et
al., 1997, 1998; Umansky et al., 1998). Thus, it is quite pos-
sible that NO released from migrating PMN could have a
negative impact on nuclear NF B in IL-1 /PAF-stimulated
HUVECs. However, as shown in Fig. 4 A, inclusion of the
NO inhibitor N
G-nitro-L-arginine methyl ester (100  M;
Sigma-Aldrich) did not alter the inhibitory affect of migrat-
ing PMN on HUVEC nuclear NF B. Furthermore, addi-
tion of a NO donor (SIN at 300  M for up to 2 h) to IL- /
PAF-stimulated HUVECs also had no impact on nuclear
NF B (unpublished data). Finally, endothelial cells isolated
from the hearts of wild-type mice were stimulated with IL-
 /PAF (recombinant mouse) and allowed to interact with
PMN isolated from iNOS-deficient mice. These iNOS-defi-
cient PMN were also capable of decreasing the levels of nu-
clear NF B in endothelial cells (Fig. 4 B). Collectively, these
observations do not support a role for NO in the negative ef-
fect of migrating PMN on endothelial cell nuclear NF B.
Our findings that PMN-derived NO is not involved in
the decrease in IL-1 /PAF-induced increase in HUVEC nu-
clear NF B appear to contradict the results of previous stud-
ies indicating a role for NO in inhibiting cytokine induced
activation of NF B (De Caterina et al., 1995; Spiecker et
al., 1997, 1998; Umansky et al., 1998). In the previous
works, NO donors were coincubated with the cytokines, i.e.,
NO was being generated during cytokine stimulation. In the
present paper, we assessed the role of NO in decreasing HU-
VEC nuclear NF B after its activation and translocation to
the nucleus. Thus, although NO may prevent cytokine-
induced activation of NF B, it may not be capable of
decreasing nuclear NF B after its accumulation within
HUVEC nuclei.
Figure 3. The negative impact of PMN transendothelial migration 
on nuclear NF B in IL-1 –activated HUVECs does not require PMN 
degranulation or PMN-derived elastase. The experimental conditions 
were the same as described in Fig. 2 B, and nuclear extracts were 
assessed for NF B content by EMSA. (A) Neutroplasts (anuclear PMN 
devoid of granules) decreased nuclear NF B in HUVECs when 
induced to migrate across IL-1 –activated HUVEC monolayers by 
a PAF gradient (IL-1 /PAF). (B) An elastase inhibitor (L 658 758) did 
not prevent the decrease in nuclear NF B induced by PMN trans-
endothelial migration (compare lane 2 with lane 3). Results presented 
are representative of three experiments.
Figure 4. PMN-derived NO does not play a role in the negative 
impact of PMN transendothelial migration on nuclear NF B in 
IL-1 –activated HUVECs. The experimental conditions were the 
same as described in Fig. 2 B, and nuclear extracts were assessed for 
NF B content by EMSA. (A) An inhibitor of NO synthase (N
G-nitro-
L-arginine methyl ester) did not prevent the decrease in nuclear 
NF B in IL-1 –activated HUVECs induced by migrating PMN
(compare lane 3 with lane 4). (B) PMN isolated from iNOS-deficient 
mice (iNOS-KO PMN) reduced endothelial cell nuclear NF B to 
the same extent as PMN isolated from their wild-type counter-
parts (WT-PMN) when induced to migrate across IL-1 –activated 
mouse cardiac endothelial cells by a PAF gradient (IL-1 /PAF).
Results are representative of three experiments.T
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Adhesive interactions with HUVECs play an important 
role in the decrease in HUVEC nuclear NF B during 
PMN transendothelial migration
PMN adhesive interactions with endothelial cells mediated
by CD18–ICAM-1 are a prerequisite for PMN transendo-
thelial migration (Granger and Kubes, 1994; Kvietys et al.,
1996; Panes and Granger, 1998; Wang and Springer, 1998).
Thus, we assessed whether these adhesive interactions play a
role in the decrease in HUVEC nuclear NF B during PMN
migration across HUVEC monolayers. To this end, we as-
sessed the effects of an mAb directed to CD18 (IB4; 40  g/
ml) on the PMN-mediated decrease in nuclear NF B in IL-
 /PAF-stimulated HUVECs. As shown in Fig. 5 A, inclu-
sion of the mAb prevented the decrease in HUVEC nuclear
NF B; the NF B level was the same as in the absence of
PMN–endothelial cell interactions. Based on previous works
(Yoshida et al., 1992) and the present paper (legend to Fig.
5), the mAb directed to CD18 decreases adhesion of PMN
to HUVECs and prevents the subsequent transendothelial
migration (legend to Fig. 5). Although this approach pro-
vided useful information, it did not address the issue of
whether PMN adhesion to HUVECs or PMN transendo-
thelial migration, per se, was the critical event involved in the
decrease in HUVEC nuclear NF B. Thus, we next assessed
the effects of fixed PMN in this system. Fixed PMN adhere
to HUVECs, but do not migrate across the monolayers
(Cepinskas et al. 1999. FASEB J. 13(4):A178, Abstract and
legend to Fig. 5). Fixed PMN failed to induce a decrease in
nuclear levels of NF B in IL- /PAF-stimulated HUVECs
(Fig. 5 B). Together, these findings suggest that the process
of PMN transendothelial migration may be more important
than the initial PMN adhesive interactions with HUVECs.
PMN adhesion to HUVECs and transendothelial migra-
tion is dependent on the interaction of adhesion molecules
on both PMN and HUVECs. The firm adhesion of PMN
to HUVECs is mediated by CD18–ICAM-1 (Granger and
Kubes, 1994; Kvietys et al., 1996; Panes and Granger, 1998;
Wang and Springer, 1998), and transendothelial migration
is dependent on homotypic adhesive interactions between
PECAM-1 on PMN and HUVECs (Muller, 1995; Liao et
al., 1997; Thompson et al., 2001). Both ICAM-1 and PE-
CAM-1 are constitutively expressed on HUVECs; with
ICAM-1 expression being punctate on the entire surface,
whereas PECAM-1 expression being more concentrated at
the interendothelial junctions (Muller et al., 1989; Kishi-
moto et al., 1999). Furthermore, both endothelial ICAM-1
and PECAM-1 can induce intracellular signaling (Gurub-
hagavatula et al., 1998; Etienne-Manneville et al., 2000;
O’Brien et al., 2001). Thus, we assessed whether cross-link-
ing of ICAM-1 or PECAM-1 (in the absence of PMN)
would influence the nuclear levels of NF B in IL- /PAF-
stimulated HUVECs. As shown in Fig. 6 A, cross-linking of
ICAM-1 did not affect the nuclear levels of NF B in IL- /
PAF-stimulated HUVECs (Fig. 6 A, compare lane 3 with
lane 1). By contrast, cross-linking of PECAM-1 resulted in a
decrease in HUVEC nuclear levels of NF B (Fig. 6 A, com-
pare lane 1 with lane 2). To further probe for a role for
PECAM-1, endothelial cells derived from the hearts of
PECAM-1–deficient mice were activated with mouse re-
combinant IL-1 /PAF and allowed to interact with mouse
PMN in the migration assay. As shown in Fig. 6 B, PMN
did not decrease the levels of nuclear NF B in PECAM-1–
deficient endothelial cells. In control experiments, we noted
that PMN migrating across endothelial cells from wild-type
mice (expressing PECAM-1) did decrease nuclear NF B
(Fig. 6 C). Collectively, these observations suggest that en-
gagement of PECAM-1 (but not ICAM-1) on endothelial
cells by migrating PMN plays an important role in decreas-
ing the IL-1 /PAF-induced accumulation of NF B in en-
dothelial cell nuclei.
The decrease in nuclear NF B induced 
by PMN transendothelial migration 
has functional consequences
Next, we assessed whether any functional consequences rele-
vant to inflammation were realized by this ability of migrat-
ing PMN to decrease nuclear NF B in IL-1 /PAF-activated
Figure 5. PMN interactions with adhesion molecules on HUVECs 
play a role in the negative impact on nuclear NF B induced by 
PMN transendothelial migration across IL-1 –stimulated HUVECs. 
The experimental conditions were the same as described in Fig. 2 B, 
and nuclear extracts were assessed for NF B content by EMSA. 
(A) An mAb directed to CD18 prevented the decrease in nuclear 
NF B in IL-1 /PAF-stimulated HUVECs induced by migrating PMN 
(compare lane 3 with lane 4). (B) Interaction of fixed PMN with 
HUVECs did not have a negative impact on nuclear NF B of 
IL-1 /PAF-stimulated HUVECs (lane 3). Results shown are represen-
tative of three experiments. 1-h transendothelial migration of PMN, 
PMN plus CD18 mAb, or fixed PMN were 80.3   0.7, 16.4   1.3, 
or 7.9   1.4, respectively. 30-min adhesion of PMN, PMN plus 
CD18 mAb, or fixed PMN to HUVEC monolayers on nonporous 
surface were 20.1   3.2, 5.7   0.8, or 9.6   0.9, respectively.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
Negative feedback regulation of NF B by PMN | Cepinskas et al. 647
HUVECs. Our approach was to stimulate HUVEC mono-
layers with IL-1 /PAF as in the previous experiments. Sub-
sequently, these monolayers were either interacted with
PMN or not. 1 or 12 h later, the HUVEC monolayers were
restimulated with IL-1 /PAF, and three endpoints relevant
to inflammation were assessed: (1) nuclear mobilization of
NF B; (2) HUVEC surface levels of ICAM-1; and (3)
PMN transendothelial migration. Because the results ob-
tained with a 1-h hiatus between cytokine challenges were
qualitatively and quantitatively similar, only the data ob-
tained with a 12-h hiatus are presented and discussed.
The effects of PAF-induced PMN transendothelial migra-
tion across IL-1 –stimulated HUVECs on the nuclear levels
of NF B after a subsequent stimulation of HUVECs with
IL-1  are shown in Fig. 7 A. Lanes 1–3 of Fig. 7 A show
that IL-1  can induce an increase in HUVEC nuclear
NF B that is dramatically decreased if PMN are allowed to
migrate across the HUVEC monolayers. If PMN were not
interacted with the HUVEC monolayers, a second challenge
with IL-1  resulted in a greater increase in nuclear accumu-
lation of NF B than that noted with the first challenge (Fig.
7 A, lane 4). If PMN were allowed to migrate across IL-1 –
stimulated HUVEC monolayers, the second challenge with
IL-1  did not result in an increase in HUVEC nuclear
NF B. These findings indicate that allowing PMN to mi-
grate across HUVEC monolayers initially challenged with
IL-1  renders them refractory to a second challenge in terms
of NF B mobilization to the HUVEC nucleus.
The effects of PAF-induced PMN transendothelial migra-
tion across IL-1 –stimulated HUVECs on ICAM-1 expres-
sion on the surface of HUVECs after a subsequent challenge
of HUVECs with IL-1  are shown in Fig. 7 B. The initial
stimulation increased ICAM-1 surface expression on HU-
VECs. The surface levels of ICAM-1 were not affected by
subsequent induction of PMN transendothelial migration. If
PMN were not interacted with the HUVEC monolayers af-
ter the initial challenge, a second challenge with IL-1  re-
sulted in a greater increase in surface levels of ICAM-1 than
that observed after the first challenge. If PMN were allowed
to migrate across IL-1 –stimulated HUVECs, the second
challenge with IL-1  resulted in a diminished increase in
ICAM-1 surface levels on HUVECs as compared with the
initial challenge with IL-1 . In general, cytokine-induced ex-
pression of ICAM-1 on HUVECs reaches maximal levels
within 6–8 h, and this enhanced expression is maintained for
up to 72 h (Kvietys and Granger, 1993). In the present work,
ICAM-1 expression on HUVECs was less after the second
cytokine challenge than the first, if PMN were allowed to
migrate across the monolayers (Fig. 7 B; compare bar 4 with
bar 5). The exact explanation for this observation is not en-
tirely clear. One explanation may be that during PMN
transendothelial migration, PMN-derived elastase becomes
associated with HUVECs (Cepinskas et al., 1999a) and pro-
teolytically cleaves ICAM-1 (Champagne et al., 1998). Irre-
spective of the explanation, our findings suggest that allow-
ing PMN to migrate across HUVEC monolayers renders
them refractory to a second challenge with respect to induc-
tion of an increase in HUVEC surface levels of ICAM-1.
The effects of PAF-induced PMN transendothelial mi-
gration across IL-1 –stimulated HUVECs on the PMN
transendothelial migration after a subsequent challenge of
HUVECs with IL-1  are shown in Fig. 7 C. The initial
stimulation with IL-1  resulted in an increase in PMN
transendothelial migration in response to a chemotactic gra-
dient induced by PAF. If PMN were not allowed to interact
with the HUVEC monolayers after the initial challenge with
Figure 6. Engagement of PECAM-1 on endothelial cells plays a 
role in the decrease in nuclear NF B in IL-1 –activated endothelial 
cells. (A) HUVEC monolayers were stimulated with IL-1 /PAF and 
ICAM-1 or PECAM-1 were cross-linked as described in Materials 
and methods. Cross-linking of PECAM-1 (mAb-PECAM-1), but not 
ICAM-1 (mAb-ICAM-1), resulted in a decrease in nuclear NF B in 
IL-1 /PAF-stimulated HUVECs in the absence of PMN. (B) Cardiac 
endothelial cells were isolated from wild-type mice (lanes 1, 2, and 5) 
or PECAM-1–deficient mice (lane 3, The Jackson Laboratory; lane 4, 
obtained from Dr. W.A. Muller). Mouse PMN adhesive interactions 
with PECAM-1–deficient endothelial cells did not affect the increase 
in nuclear NF B induced by IL-1 /PAF. In these experiments, 58% 
(lane 3) and 54% (lane 4) of the PMN migrated across PECAM-1–
deficient endothelial cells after 1 h of coincubation. (C) Mouse 
PMN adhesive interactions with endothelial cells from wild-type mice 
(expressing PECAM-1) reduced endothelial cell nuclear NF B induced 
by IL-1 /PAF. Results shown are representative of three experiments.T
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IL-1 , PAF-induced PMN migration after the second chal-
lenge with IL-1  was similar to that noted after the first IL-
1  challenge. If the PMN were allowed to migrate across the
HUVEC monolayers after the initial challenge with IL-1 ,
the PAF-induced PMN transendothelial migration after the
second IL-1  challenge was reduced by  45% (Fig. 7 C,
compare bar 2 with bar 4).
Discussion
During the systemic inflammatory response, circulating cy-
tokines interact with the vascular endothelium, resulting in
the activation and nuclear translocation of NF B (Collins et
al., 1995; Winyard and Blake, 1997). In turn, NF B trans-
activates genes encoding for various cytokines. This results
in a positive feedback loop that could amplify the inflamma-
tory response, a situation that could be potentially detrimen-
tal to the host. Fortunately, there are negative feedback
mechanisms in place that limit an excessive and prolonged
inflammatory response on NF B translocation to the nu-
cleus. For example, in addition to transactivating various
proinflammatory genes, NF B also transactivates the gene
encoding for its inhibitory protein, I B (Brown et al., 1993;
Baldwin, 1996). I B binds to NF B and prevents further
translocation of this nuclear transcription factor, thereby
preventing an excessive, uncontrolled inflammatory re-
sponse. In the present paper, we provide evidence for the ex-
istence of another negative feedback mechanism impacting
on NF B. We show that the IL-1 –induced increase in
HUVEC nuclear NF B can be dramatically reduced by
PMN transendothelial migration (Figs. 2–5). In addition,
we provide evidence to implicate PECAM-1 in this negative
feedback mechanism (Fig. 6). To our knowledge, this is first
demonstration of the existence of this novel negative feed-
back on NF B.
During the course of our experiments, we were aware of
one potential caveat to the interpretation of the data. Previ-
ous works have shown that, during preparation of samples of
endothelial cell monolayers for assay, any PMN associated
with the monolayers could lead to artificial proteolysis of
proteins under investigation (Moll et al., 1998). In our ex-
periments, we minimized the potential for this artifact to
impact on our results in two ways. For EMSA, we allowed
the PMN to completely leave the apical aspect of the HU-
VEC monolayers, and we maximized the antiproteolytic ac-
tivity of the buffers used to extract nuclear proteins (Mc-
Donald et al., 1997). In addition, we used another approach
to assess the negative impact of PMN transendothelial mi-
gration on the IL-1 –induced increase in HUVEC nuclear
NF B, i.e., confocal microscopy (Fig. 2). This approach in-
Figure 7. The decrease in nuclear NF B induced by PMN migrating 
across IL-1 /PAF-stimulated HUVECs has functional consequences 
with respect to the inflammatory process. HUVEC monolayers 
were stimulated with IL-1 /PAF (I) for 4 h, and subsequently were 
interacted with PMN or not interacted with PMN. 12 h later, the 
HUVEC monolayers were rechallenged with IL-1 /PAF (II) for 4 h, 
and various endpoints relevant to inflammation were assessed. 
(A) If PMN were not reacted with HUVECs after the first challenge, 
the second challenge resulted in a greater level of nuclear NF B as 
detected by EMSA (lane 4). If PMN transendothelial migration was 
induced after the first challenge, the second challenge did not result 
in nuclear accumulation of NF B (lane 5). Lane 6 shows data 
obtained when IL-1 /PAF stimulation was maintained over the 
entire experimental period of 16 h (control). Results shown are 
representative of three experiments. (B) If PMN were not interacted 
with HUVECs after the first challenge, the second challenge resulted 
in greater HUVEC surface levels of ICAM-1 as detected by cell ELISA 
(bar 4). If PMN transendothelial migration was induced after the first 
challenge, the second challenge resulted in less ICAM-1 induction 
on the surface of ICAM-1 (compare bar 4 with bar 5). n   3. (C) If 
PMN were not interacted with HUVECs after the first challenge, the 
second challenge resulted in the same degree of PMN transendothelial 
migration as after the first challenge (compare bar 2 with bar 3). 
If PMN transendothelial migration was induced after the first 
challenge, the second challenge resulted in less PMN transendothelial 
migration (bar 4). n   3. Dark bars in B and C show data obtained 
when IL-1 /PAF stimulation was maintained over the entire experi-
mental period of 16 h (control).T
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volved the fixation of all cells under study, and thus pre-
vented PMN degranulation during sample preparation. Fi-
nally, addition of the PMN protease (elastase) directly to IL-
1 –stimulated HUVECs had no impact on nuclear NF B.
Together, these observations indicate that artifactual pro-
teolysis was not an issue in our experiments.
PMN adhesion to HUVECs and transendothelial migra-
tion is dependent on the interaction of adhesion molecules
on both PMN and HUVECs. The firm adhesion of PMN
to HUVECs is mediated by CD18–ICAM-1 (Granger and
Kubes, 1994; Kvietys et al., 1996; Panes and Granger, 1998;
Wang and Springer, 1998), whereas transendothelial migra-
tion is dependent on homotypic adhesive interactions be-
tween PECAM-1 on PMN and HUVECs (Muller, 1995;
Liao et al., 1997; Thompson et al., 2001). Furthermore,
both endothelial ICAM-I and PECAM-1 can induce intra-
cellular signaling. Cross-linking of ICAM-1 on rat brain en-
dothelial cells promotes intracellular calcium signaling that
results in cytoskeletal rearrangement and facilitates lympho-
cyte transendothelial migration (Etienne-Manneville et al.,
2000). Interestingly, recent works indicate that ICAM-1
transfected into CHO cells can support PMN migration
across these transfected CHO monolayers; an effect requir-
ing the presence of the cytoplasmic domain of ICAM-1
(Sans et al., 2001). This latter observation indicates that
ICAM-1 can contribute to PMN transendothelial migra-
tion. Finally, engagement of PECAM-1 on HUVECs with
antibodies results in intracellular signaling (increased intra-
cellular calcium); an effect that requires the presence of the
intracellular domain (Gurubhagavatula et al., 1998; O’Brien
et al., 2001). Thus, we assessed whether cross-linking of ei-
ther ICAM-1 or PECAM-1 (in the absence of PMN) would
have an impact on the levels of nuclear NF B in IL-1 –
stimulated HUVECs. Of these two endothelial cell adhesion
molecules implicated in PMN transendothelial migration,
only engagement and cross-linking of PECAM-1 was capa-
ble of mimicking the effects of PMN transendothelial mi-
gration on nuclear NF B in cytokine-stimulated HUVECs
(Fig. 6 A). Furthermore, the IL-1 –induced increase in nu-
clear NF B was unaffected by PMN adhesive interactions
with endothelial cells derived from PECAM-1–deficient
mice (Fig. 6 B). A role for PECAM-1 (but not ICAM-1) in
intracellular signaling has also been shown in another system
(Ferrero et al., 2003). The specific intracellular signals that
are initiated by engagement of endothelial cell PECAM-1 by
PMN to decrease nuclear NF B are, at present, unclear and
warrant further attention.
Our findings also indicate that the decrease in nuclear
NF B in IL-1 –stimulated HUVECs by migrating PMN
has functional consequences relevant to the inflammatory
process. When PMN transendothelial migration was al-
lowed to occur across IL-1 –stimulated HUVECs, a subse-
quent challenge with IL-1  resulted in less (1) nuclear
NF B accumulation; (2) ICAM-1 surface levels; and (3)
PMN transendothelial migration (Fig. 7). It is worth noting
that although there is a striking loss of NF B under these
circumstances, there are only modest decreases in surface
levels of ICAM-1 (48%) and PMN transendothelial migra-
tion (45%). These observations indicate that other factors
besides NF B maybe involved in the residual proinflamma-
tory response observed after the second challenge with the
cytokine. There may be nuclear transcription factors that are
not negatively impacted by PMN migration which may con-
tribute to the inflammatory response. Alternatively, the re-
sidual response may be independent of nuclear transcription
factors, i.e., other as yet unidentified proinflammatory medi-
ators may be involved. Irrespective of the explanation, these
observations indicate that allowing PMN to migrate across
IL-1 –stimulated HUVECs results in a decreased proin-
flammatory response to a second IL-1  challenge.
The phenomenon described herein is very reminiscent of
the development of tolerance to cytokine or LPS stimulation
in a variety of cells (Fraker et al., 1988; Laegreid et al., 1995;
Lush et al., 2000). However, there is a major difference in
the development of this refractoriness to cytokine stimula-
tion between classical tolerance and the tolerance described
in the present paper. In classical tolerance, an initial chal-
lenge with a cytokine or oxidant stress results in a decreased
responsiveness to a subsequent challenge with the same stim-
ulus (Cepinskas et al., 1999b; Lush et al., 2000); an effect
independent of PMN interactions with the cells. In the
present paper, we have provided evidence that allowing for
PMN transendothelial migration between the two chal-
lenges can also result in the development of tolerance. To
our knowledge, this is the first direct demonstration of such
a phenomenon. Further studies are warranted to unravel the
mechanisms involved in the development of this form of tol-
erance.
Materials and methods
Induction of sepsis in mice
Sepsis was induced in wild-type (C57BL/6) and ICAM-1–deficient mice
(C57BL/6 background; Jackson ImmunoResearch Laboratories) by CLP as
described previously (Astiz et al., 1994; Kato et al., 1995; Lush et al.,
2001). The mice were anesthetized with a subcutaneous injection of 150
mg/kg ketamine and 7.5 mg/kg xylazine. After a midline incision, the
cecum was exposed, ligated at the level of the ileo-cecal valve, and its
contents expelled by an incision at the antimesenteric border. The laparot-
omy was closed and a 1-ml subcutaneous injection of saline was given for
fluid resuscitation. Sham-operated mice underwent laparotomy, but no ce-
cal ligation or perforation. 6 h after induction of CLP, the hearts and lungs
of the mice were harvested and tissue processed for assessment of (1) tis-
sue accumulation of PMN; and (2) the presence of NF B in nuclear ex-
tracts. PMN accumulation was assessed by measuring tissue MPO activity
as described previously (Lush et al., 2001). NF B accumulation in nuclear
extracts was assessed by the EMSA as described in the EMSA for NF B sec-
tion (Neviere et al., 1999).
Endothelial cells
HUVECs were harvested from umbilical cords by collagenase treatment
and cultured as described previously (Yoshida et al., 1992; Cepinskas et
al., 1999a). Primary through second passage HUVECs were used in exper-
iments. When necessary, mouse (C57BL/6 wild type or PECAM-1 deficient
on C57BL/6 background; The Jackson Laboratory and gift from Dr. W.
Muller) myocardial endothelial cells were harvested as described previ-
ously (Rui et al., 2001).
Leukocytes
Human neutrophilic PMN were isolated from venous blood of healthy
adults using standard dextran sedimentation and gradient separation on
HISTOPAQUE
®-1077 (Sigma-Aldrich; Cepinskas et al., 1999b). This pro-
cedure yields a PMN population that is 95–98% viable (trypan blue exclu-
sion) and 98% pure (acetic acid-crystal violet staining). When necessary,
PMN cytoplasts (neutroplasts) were prepared as described previously
(Cepinskas et al., 1999a). In brief, PMN in 12.5% Ficoll solution were lay-
ered over a discontinuous gradient of 16 and 25% Ficoll and centrifuged atT
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81,000 g. Neutroplasts were harvested from the 12.5%/16% interface. This
procedure yields a population of anucleated PMN devoid of granules. For
some experiments, PMN were fixed for 5 min using 3% PFA in PBS. When
necessary, PMN were isolated from whole blood of mice (C57BL/6 wild
type or iNOS-deficient on C57BL/6 background; The Jackson Laboratory)
by centrifugation on a NIM-2 gradient (Cardinal Associates, Inc.).
PMN transendothelial migration
PMN transendothelial migration was assessed as described previously
(Cepinskas et al., 1997, 1999a). Endothelial cells were grown to confluence
on 25  g/ml fibronectin-coated Falcon cell culture inserts (3- m-diam
pores) and stimulated with 1 ng/ml IL-1  (R&D Systems) for 4 h. Neutro-
phils were added to the endothelial cell monolayers and allowed to migrate
across them for 1 h in the presence of PAF (10
 10 M; Sigma-Aldrich) in the
basal compartment. This period of time was sufficient to ensure that the bulk
of the PMN had traversed the monolayer. To quantitate changes in the rate
of PMN transendothelial migration, PMN were labeled with 
51Cr, and PMN
migration was assessed 30 min after coincubation with HUVEC monolay-
ers, i.e., before PMN transendothelial migration was complete.
EMSA for NF B
Nuclear protein from whole tissue or endothelial cells was extracted as de-
scribed previously (McDonald et al., 1997; Cepinskas et al., 1999b). For
EMSA, 3  g of total nuclear proteins was incubated with 1.0 pmol of
double-stranded  [
32P]ATP end-labeled oligonucleotides containing con-
sensus binding sequences for NF- B (sense strand 5 -AGGGACTTTC-
CGCTGGGGACTTTCC-3 ) in a binding buffer (10 mM Hepes, pH 7.9, 80
mM NaCl, 3 mM MgCl2, 0.1 mM EDTA, 1 mM DTT, 1 mM PMSF, and
10% glycerol) as described previously (Bielinska et al., 1990; Cepinskas et
al., 1999b). After electrophoresis under nondenaturing conditions (0.5 
TBE buffer), the gels were dried and the radioactive bands were visualized
on X-ray films.
Laser scanning confocal microscopy for NF B
HUVECs were prepared for immunofluorescence analysis as described
previously (Cepinskas et al., 1999a). HUVECs were treated with 2  g/ml
rabbit pAb NF B p65 (A; Santa Cruz Biotechnology, Inc.) and Texas red–
conjugated secondary goat anti–rabbit IgG (Molecular Probes, Inc.). The
nuclei were stained with Hoechst 33342. The distribution of HUVEC
NF B p65 subunits was analyzed by confocal microscopy.
Cell ELISA for ICAM-1
Cell surface levels of ICAM-1 were measured as described previously
(Lush et al., 2000). In brief, PFA-fixed (3%) HUVECs were incubated with
primary mAb directed against ICAM-1 (RR1/1, IgG1; Biosource Interna-
tional). The antibody binding intensity was evaluated using a Mouse Extra-
vidin Peroxidase Staining Kit (Sigma-Aldrich).
Adhesion molecule cross-linking
Cross-linking of ICAM-1 was induced as described previously (Etienne-
Manneville et al., 2000) with some modifications. In brief, HUVECs were
grown in 35-mm Petri dishes and stimulated with 1 ng/ml IL-1  for 4 h.
HUVEC ICAM-1 was engaged by treatment of HUVECs with a primary
mAb (20  g/ml) directed against ICAM-1 (RR1/1, IgG1; Biosource Interna-
tional) for 30 min, and cross-linking was induced by subsequent addition
of 5  g/ml rabbit anti–mouse antibodies (DakoCytomation) for an addi-
tional 30 min. Cross-linking of PECAM-1 was done in a similar manner
(Berman and Muller, 1995; Gurubhagavatula et al., 1998) using an mAb
(20  g/ml) against PECAM-1 (hec7, IgG2a; a gift from Dr. W.A. Muller,
Cornell University School of Medical Sciences, New York, NY).
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